organo phosphorus poisioning patient apporoach diagnosis managemant and treatment
Reading File
Finding Sources
Finding Sources
Searching PubMed
"organophosphate poisoning" AND management
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information. Let me compile the full, detailed answer.
Organophosphorus (OP) Poisoning: Patient Approach, Diagnosis & Management
1. Overview & Epidemiology
Organophosphorus (OP) compounds are the most common insecticide-related cause of death worldwide, with >150,000 pesticide poisoning deaths per year globally. Common agents include parathion, malathion, chlorpyrifos, diazinon, TEPP, and acephate. Exposures occur via:
- Deliberate self-poisoning (most common globally)
- Occupational/agricultural exposure
- Accidental ingestion
- Transdermal, inhalational, or conjunctival absorption
2. Mechanism (Pathophysiology)
OP compounds irreversibly inhibit acetylcholinesterase (AChE) via phosphorylation of the enzyme's active site. This leads to:
- Accumulation of acetylcholine (ACh) at all cholinergic synapses
- Overstimulation followed by paralysis of:
- Muscarinic receptors (parasympathetic postganglionic)
- Nicotinic receptors (neuromuscular junctions, autonomic ganglia)
- CNS cholinergic synapses
"Aging" = permanent irreversible binding of OP to AChE. The faster aging occurs, the less effective oxime therapy becomes. This is why early pralidoxime is critical.
Tintinalli's Emergency Medicine, p. 1342
3. Clinical Features
The classic toxidrome is a cholinergic crisis, divided into three syndromes:
A. Muscarinic Effects (DUMBELS / SLUDGE)
| Mnemonic | Symptoms |
|---|---|
| D - Defecation/Diarrhea | Uncontrollable bowel urgency |
| U - Urination | Involuntary urination |
| M - Miosis | Pinpoint pupils (hallmark) |
| B - Bradycardia, Bronchospasm | Wheeze, heart rate <60 |
| E - Emesis | Nausea, vomiting |
| L - Lacrimation | Excessive tearing |
| S - Salivation/Secretions | Drooling, bronchorrhea |
Additional: abdominal cramps, diaphoresis (sweating)
B. Nicotinic Effects (Skeletal Muscle / Ganglia)
- Muscle fasciculations (pathognomonic)
- Muscle weakness and flaccid paralysis
- Tachycardia (can override bradycardia)
- Hypertension (early)
Mnemonic: "Days of the week" - Diaphoresis, Tachycardia, Hypertension, Mydriasis (NB: can occur despite miosis)
C. CNS Effects
- Anxiety, restlessness, confusion
- Slurred speech, tremors, ataxia
- Seizures/convulsions
- Coma and death from respiratory/circulatory center depression
P C Dikshit Textbook of Forensic Medicine and Toxicology; Tintinalli's Emergency Medicine, p. 1343
Death results from a combination of: bronchorrhea + respiratory muscle paralysis + CNS depression.
4. Intermediate Syndrome
A distinct syndrome occurring 24-96 hours after the acute cholinergic crisis (and after apparent recovery):
- Proximal limb weakness
- Neck flexor weakness
- Respiratory paralysis
- Cranial nerve palsies
- Occurs due to prolonged AChE inhibition at nicotinic receptors
- Requires ICU ventilatory support; oximes and atropine are NOT helpful here
5. Delayed Neuropathy (OPIDN)
- Occurs 2-5 weeks after acute poisoning
- Caused by inhibition of neuropathy target esterase (NTE)
- Presents as distal sensorimotor peripheral neuropathy (predominantly motor)
- Associated with specific compounds (e.g., TOCP, trichlorfon)
- No specific treatment; recovery over months
Adams and Victor's Principles of Neurology, 12th Ed.
6. Diagnosis
Clinical Diagnosis
- History of exposure + typical cholinergic toxidrome
- Miosis + bronchorrhea + fasciculations = high specificity
Atropine Test
- Inject 2 mg atropine IV: a normal individual shows signs of atropinization (dry mouth, tachycardia, mydriasis). In OP poisoning, no atropinization occurs because excess ACh competitively overwhelms the effect.
Laboratory Diagnosis
| Test | Detail |
|---|---|
| RBC AChE (true cholinesterase) | Most specific; falls to 25-85% of normal in OP poisoning. Symptoms appear when level falls to <20% of normal. Normal: 77-142 U/L (RBC). Better indicator than plasma. |
| Plasma (pseudo)cholinesterase | Normal: 41-140 U/L. Falls earlier but less specific. |
| Periodic monitoring | Helps track recovery; levels correlate with clinical progress. |
Sample: 5 mL venous blood in a fluoride oxalate bottle.
Note: ~3% of the population has congenital cholinesterase deficiency; levels also fall in severe liver disease.
Other Workup
- ABG (respiratory failure monitoring)
- ECG (QTc prolongation, bradycardia)
- CXR (aspiration, pulmonary edema)
- BMP/electrolytes, glucose
- Urine for OP metabolites (p-nitrophenol for parathion)
P C Dikshit Textbook of Forensic Medicine, p. 9725-9755
7. Management
Step 1 - Decontamination (PRIORITY #1 + STAFF SAFETY)
- PPE mandatory: healthcare workers must wear neoprene/nitrile gloves and protective clothing (NOT latex - OPs can penetrate)
- Remove ALL patient clothing, place in sealed plastic bags (hazardous waste)
- Wash patient with copious soap and water - scalp, hair, skin folds, fingernails, conjunctivae
- Handle runoff water as hazardous material
- Do NOT transport by helicopter (risk of secondary exposure to crew)
Step 2 - Airway & Supportive Care
- 100% O2 via non-rebreather mask
- Cardiac monitor + pulse oximetry
- IV access (2 large-bore)
- Intubate early if: coma, seizures, respiratory failure, severe bronchospasm, excessive secretions
- Use succinylcholine with caution for RSI - OP poisoning prolongs its action (AChE inhibition prevents succinylcholine breakdown). Prefer rocuronium if available.
- Gentle suctioning of airway secretions
Step 3 - Antidote 1: ATROPINE
Atropine is the primary antidote - it reverses muscarinic effects (bronchorrhea, bradycardia, miosis, secretions). It does NOT reverse nicotinic effects (fasciculations, weakness).
| Parameter | Adult Dose | Pediatric Dose |
|---|---|---|
| Initial bolus | 1.2-3 mg IV (severity-guided) | 0.05 mg/kg IV |
| Doubling | Double dose every 5 min until adequate atropinization | Same principle |
| Maintenance infusion | 0.4-4 mg/hr IV (10-20% of total atropinizing dose/hour) | Adjusted |
Endpoints of adequate atropinization (not mydriasis!):
- Clear chest on auscultation (bronchorrhea resolved)
- Heart rate >80 beats/min
- Systolic BP >80 mmHg
- Dry secretions
Avoid atropine toxicity: absent bowel sounds, hyperthermia, delirium.
Important: Tachycardia is NOT a contraindication to atropine in OP poisoning - tachycardia can be secondary to bronchospasm/hypoxia, which atropine can improve.
Tintinalli's Emergency Medicine, Table 201-3, p. 1344
Step 4 - Antidote 2: PRALIDOXIME (2-PAM / Oxime)
Pralidoxime reactivates phosphorylated AChE before aging occurs. It reverses both muscarinic AND nicotinic effects.
| Parameter | Dose |
|---|---|
| Loading dose (adult) | 30 mg/kg IV (max 1-2 g), infused over 5-10 min |
| Loading dose (child) | 30 mg/kg up to 1 g in normal saline |
| Maintenance infusion | 8 mg/kg/hour for 24-48 hours |
| Timing | Give as soon as possible; may be given 24-48 hours post-exposure |
Key points:
- Most effective before aging - start immediately, do not wait for labs
- Less effective for carbamate poisoning (carbamates spontaneously hydrolyze off AChE)
- Rapid IV push can cause tachycardia, laryngospasm, and neuromuscular blockade - always infuse slowly
Step 5 - Seizures
- Benzodiazepines IV (diazepam or lorazepam) - first line
- Phenytoin is NOT effective for organophosphate-induced seizures
- Phenobarbital may be added if refractory
Step 6 - GI Decontamination
| Measure | Evidence |
|---|---|
| Gastric lavage | No proven benefit |
| Activated charcoal | No proven benefit (traditionally given within 1 hour of ingestion if airway protected) |
Summary Treatment Table
| Intervention | Details |
|---|---|
| Decontamination | Soap + water, hazardous PPE |
| Monitoring | Cardiac monitor, SpO2, 100% O2 |
| Atropine | 1.2-3 mg IV bolus, double q5min to endpoint, then infusion |
| Pralidoxime | 30 mg/kg IV over 5-10 min, then 8 mg/kg/hr x 24-48h |
| Seizures | Benzodiazepines IV |
| Gastric lavage | No proven benefit |
| Activated charcoal | No proven benefit |
Tintinalli's Emergency Medicine, Table 201-3
8. Severity Classification (WHO / Clinical)
| Grade | Cholinesterase Activity | Features |
|---|---|---|
| Mild | 20-50% of normal | Headache, miosis, nausea, dizziness |
| Moderate | 10-20% | Muscle fasciculations, weakness, bradycardia |
| Severe | <10% | Coma, seizures, respiratory failure, bronchorrhea |
9. Disposition
- Mild: observe in ED, discharge if asymptomatic after observation
- Moderate-Severe: ICU admission mandatory
- All require serial cholinesterase level monitoring
- Watch for intermediate syndrome at 24-96 hours
- Psychiatric evaluation for intentional self-poisoning
10. Carbamate Poisoning (Compare & Contrast)
- Same mechanism (AChE inhibition) but reversible (carbamates spontaneously dissociate from AChE)
- Clinical picture similar but generally milder and shorter duration
- Atropine is the antidote of choice
- Pralidoxime is generally NOT recommended for pure carbamate poisoning (may worsen toxicity in some studies)
Tintinalli's Emergency Medicine, Carbamates section
Recent Evidence (2025-2026)
- A 2025 systematic review (PMID 38797902) evaluated glycopyrrolate as an alternative to atropine in OP/carbamate poisoning - may offer benefit in certain settings.
- A 2026 umbrella review (PMID 42258859) of therapeutic interventions in OP poisoning summarized current evidence across multiple systematic reviews. The broad conclusion remains that atropine + early oxime therapy is the cornerstone, with ongoing debate about optimal pralidoxime dosing and duration.
Quick Memory Aid: SLUDGE + DUMBELS + 3 Antidotes
S - Salivation
L - Lacrimation
U - Urination
D - Defecation
G - GI cramps
E - Emesis
Antidotes: ATROPINE (muscarinic) + PRALIDOXIME (reactivates AChE) + BENZODIAZEPINES (seizures)
This is a shared conversation. Sign in to Orris to start your own chat.